Islet grafting and imaging in a bioengineered intramuscular space

Area of Science:

• Regenerative Medicine
• Transplantation Biology
• Biomedical Engineering

Background:

• The liver's hepatic portal system is not always optimal for islet transplantation.
• Extrahepatic sites are being explored to improve islet transplant outcomes.
• This study investigates a bioengineered intramuscular site for enhanced islet survival and monitoring.

Purpose of the Study:

• To evaluate an intramuscular site for islet transplantation using a bioengineered angiogenic scaffold.
• To assess the efficacy of real-time, noninvasive monitoring of transplanted beta cell mass via Positron Emission Tomography (PET) imaging.
• To determine if enhanced neovascularization improves islet engraftment and survival.

Main Methods:

• Streptozotocin-induced diabetic rats received intramuscular angiogenic scaffolds followed by syngeneic islet transplants.
• Recipients were monitored using blood glucose levels, glucose tolerance tests, and PET imaging with [11C] dihydrotetrabenazine.
• Graft histopathology included insulin staining and microvascular density assessment.

Main Results:

• Islet transplantation was most successful in rats pretreated with angiogenic scaffolds, leading to hyperglycemia reversal.
• PET imaging, insulin staining, and microvascular density correlated with improved islet survival and angiogenesis.
• The intramuscular site demonstrated successful islet engraftment and function.

Conclusions:

• Increased neovascularization at an intramuscular site significantly enhances islet transplant engraftment and survival.
• Utilizing a nonhepatic site avoids intrahepatic complications and enables real-time PET monitoring of beta cell mass.
• These findings support improved islet implantation, survival, and monitoring strategies outside the liver.